
GC19101
Cenicriviroc
Also known as (5E)-8-[4-(2-butoxyethoxy)phenyl]-1-(2-methylpropyl)-N-[4-[(S)-(3-propylimidazol-4-yl)methylsulfinyl]phenyl]-3,4-dihydro-2H-1-benzazocine-5-carboxamide
Cenicriviroc (CVC) is an oral, dual CCR2/CCR5 antagonist with nanomolar potency against both receptors
ChemicalCAS497223-25-3MW696.94FormulaC41H52N4O4S
- CAS number
- 497223-25-3
- Molecular weight
- 696.94
- Formula
- C41H52N4O4S
- Solubility
- DMSO : ≥ 107·5 mg/mL (135·55 mM)
- InChIKey
- PNDKCRDVVKJPKG-WHERJAGFSA-N
- Catalogue number
- GC19101
- Brand
- GLPBIO
Computed properties PubChem CID 11285792 · XLogP 7.5 · TPSA 105 Ų · H-bond donors 1
- XLogP
- 7.5
- TPSA
- 105 Ų
- H-bond donors
- 1
- H-bond acceptors
- 7
- Rotatable bonds
- 17
- Heavy atoms
- 50
SMILES CCCCOCCOC1=CC=C(C=C1)C2=CC/3=C(C=C2)N(CCC/C(=C3)/C(=O)NC4=CC=C(C=C4)[S@@](=O)CC5=CN=CN5CCC)CC(C)C
Computed descriptors from PubChem (CID 11285792), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il